Canterbury DHB
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia5 separates CEL-NOS and HES from haematologic malignancies with eosinophilia associated with abnormalities of:
This is of major therapeutic relevance because imatinib is only effective in the presence of a PDGFR mutation.
Topic Code: 6417